13 hours Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy The Next Web
London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the boomi…
Biotech · London · Tech · U.K.
X